Background and Aims: ECMO is increasingly being applied as lifesupport for lung transplantation patients. The aim of this study was to determine. However, the outcomes of this procedure in Lung transplantation patients have not yet been characterized. The aim of this study was to evaluated the outcome of in Lung transplantation patients supported with ECMO and to identify potential predictors of mortality in these patients.
Methods: Patients underwent lung transplantation treated with ECMO in Guangzhou Institute of Respiratory Diseases between January 2015 to August 2017 were retrospectively reviewed. Patient demographics and clinical variables were collected and analyzed. Univariate and multivariable logistic regression was performed to identify predictors of outcome in lung transplantation patients treated with extracorporeal membrane oxygenation.
Results: During the study period, 67 patients underwent lung transplantation at our institution, 21 patients were treated with ECMO. 14 patients (66.6%) were survived at 6 months. Significant predictors of survival in lung transplantation patients based on a multivariate logistic regression analysis, were advanced age and long times of preoperative mechanical ventilation and preoperative intensive care unit, a higher Acute Physiology and Chronic Health Evaluation II (APACHE II) score.
Conclusion:
Age, long times of preoperative mechanical ventilation and preoperative intensive care unit, a higher Acute Physiology and Chronic Health Evaluation II (APACHE II) score may be the major predictors of the prognosis in lung transplantation patients supported with ECMO based on a multivariate analysis. Acute and Critical Care Center, Nagasaki University Hospital, Japan Background and Aims: Septic shock or ARDS is characterized by a dysregulated vascular permeability and its treatment outcome remains poor. Most of the cases require intensive care, and its disease burden on health economics is high. Recently, we reported that macrophage phagocytosis dysfunction was regulated by serotonin (5-hydroxytryptamine; 5-HT) through Rho kinase activation (Tanaka et al. JBC.2014) . We focused on endothelial cells and we hypothesized that vascular permeability on endothelial cells would be regulated by 5-HT through Rho kinase activation. To prove this, we conducted in vitro experiment and 5-HT kinetics was assessed in clinical patient samples.
Methods: In vitro experiment, permeability upon 5-HT stimulation of endothelial monolayer determined by albumin transfer using human pulmonary microvascular endothelial cells (HPMEC).For clinical samples analysis, plasma and urine samples from healthy volunteers controls (n = 7), sepsis and ARDS (n = 46) patients in ID ward, ICU and ER at Nagasaki University Hospital were acquired after obtaining the informed consent, then serotonin metabolite (5HIAA) was measured.
Results: 5-HT significantly increased the permeability of the endothelial cells compared with the control. Treatment with Y-27632 (Rho kinase inhibitor) significantly inhibited the permeability that was induced by 5-HT stimulation. Plasma 5HIAA levels in clinical samples were significantly higher in sepsis patients compared with controls. And these elevated levels were significantly correlated with the severity indexes (SOFA score, APACHE-II score, P/F ratio, use of renal-replacement therapy) and ICU discharge rate.
Conclusion: 5-HT increased the vascular permeability of endothelial cells via the Rho kinase pathway and elevated 5HIAA were seen in severe septic shock patients, suggesting a novel mechanism by which 5-HT may disrupt the endothelium barriers and contribute to the pathogenesis of severe shock status with a vascular leak of sepsis or ARDS. Background and Aims: Previous studies suggest that obesity may be a risk factor for complications from pandemic influenza A (H1N1) or seasonal influenza infection. We aimed to examine the association between overweight/obesity and normal weight in adult critically ill patients with seasonal influenza infection in Taiwan.
Methods: This is a multicenter retrospective cohort study conducted by Taiwan Severe Influenza Research Consortium (TSIRC) which includes eight tertiary referral medical centres. Patients with virologyproven influenza infection admitted to intensive care unit between January and March 2016 were included for analysis. After excluding underweight patients, the patients were categorized in two groups by body mass index (BMI), overweight/obesity (OO, BMI ≥ 27.5 kg/m 2 ) and normal weight (NW, 27.5 > BMI ≥ 18.5 kg/m 2 ) according to local cut-point.
Results: A total of 303 patients were enrolled, and 97.4% of them with respiratory system involvement. The patients in OO group were younger than NW group (55.9 AE 13.3 years vs 62.8 AE 14.8, P < 0.001), and less organ dysfunction (Sequential Organ Failure Assessment Score, SOFA score) (9.2 AE 3.5 vs 10.7 AE 4.5, P = 0.02). Among other severity evaluation, there were no significant difference in APACHE II score, Creactive protein, lactate, and platelet count. The 30-day mortality was also lower in OO group (11% vs 24.4%, P = 0.008). Using Kaplan-Meier survival analysis to evaluate the association of 30-day mortality with different BMI category, the result showed positive correlation (log-rank test, P = 0.021). In a multivariate Cox proportional hazard regression model adjusted for sex and APACHE II (including to age factor), the normal weight comparing with overweight/obesity was independently associated with a higher 30-day mortality rate (aHR 2.027, 95% CI: 1.027-4.001, P = 0.042).
The normal weight comparing with overweight/obesity was independently associated with a higher 30-day mortality rate in critically ill patients with influenza in Asian population. Further prospective study is warranted.
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